Abstract
Ketoconazole appears to be a safe drug in the treatment of chronic cavitary histoplasmosis. Primary failure and relapse have been described, requiring amphotericin B, even after long therapy with ketoconazole. Four typical cases are presented. We caution about such potential failures and stress the importance of close observation of patients begun on therapy with ketoconazole for chronic cavitary histoplasmosis.
Original language | English (US) |
---|---|
Pages (from-to) | 914-916 |
Number of pages | 3 |
Journal | CHEST |
Volume | 95 |
Issue number | 4 |
DOIs | |
State | Published - 1989 |